Effect of VR Versus CT in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients

August 21, 2024 updated by: Muhammad Naveed Babur, Superior University

Effect of Virtual Reality Versus Conservative Treatment in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients

Virtual reality (VR) therapy has shown promising results in improving sensorimotor function of the upper extremity in chronic stroke patients compared to conservative treatments. VR offers immersive, interactive environments that can enhance motivation and engagement in rehabilitation exercises.

Study Overview

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan
        • Services Hospital,Shadman 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • Patients with a confirmed diagnosis of chronic stroke (at least 6 months post-stroke).

Age:

  • Upper Extremity Impairment:
  • Ability to provide informed consent to participate in the study.

Exclusion Criteria

  • Severe communication difficulties that would impede the ability to follow instructions during therapy.
  • Severe spasticity in the affected upper limb (Modified Ashworth Scale score of 4 or higher).
  • Other Neurological Conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group

Intervention: Patients in this group will receive traditional rehabilitation therapies, which may include:

Physical Therapy (PT): Exercises and activities aimed at improving strength, flexibility, and coordination of the upper limb.

Occupational Therapy (OT): Functional task training to enhance daily living skills and independence, focusing on the use of the upper extremity.

Manual Therapy: Techniques such as massage or joint manipulation to improve mobility and reduce pain.

Home Exercise Programs: Prescribed exercises to be performed at home to reinforce therapy sessions.

Duration and Frequency: Similar to the VR group, this regimen may involve regular sessions several times a week, with each session lasting between 30 to 60 minutes, over a comparable period.

Experimental: Exp Group

Intervention: Patients in this group will receive therapy using VR technology. This involves engaging in various sensorimotor training exercises and tasks in an immersive virtual environment. The VR sessions are designed to be interactive and adaptive, providing real-time feedback to the user. The exercises will target the improvement of motor functions, coordination, and strength of the affected upper extremity.

Duration and Frequency: The specific regimen may involve sessions several times a week, with each session lasting between 30 to 60 minutes, over a period of several weeks or months, depending on the study design.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment (FMA) for Upper Extremity
Time Frame: 12 Months

The Fugl-Meyer Assessment (FMA) for Upper Extremity is a widely used and validated tool to evaluate motor function, balance, sensation, and joint functioning in individuals who have had a stroke. It specifically assesses the sensorimotor function of the upper extremities.

Scoring:

The upper extremity section of the FMA includes 33 items, each scored on a scale of 0 to 2:

0: Cannot perform

  1. Performs partially
  2. Performs fully The maximum score for the upper extremity section is 66, indicating optimal function.
12 Months
Stroke Impact Scale (SIS)
Time Frame: 12 months

The Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates the impact of stroke on multiple dimensions, including strength, hand function, activities of daily living (ADL), mobility, communication, emotion, memory, thinking, and participation.

Each item is scored on a scale of 1 to 5:

1: Unable to do 5: Not difficult at all Higher scores indicate a lesser impact of stroke on the patient's life.

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Actual)

July 1, 2024

Study Completion (Estimated)

October 30, 2024

Study Registration Dates

First Submitted

August 21, 2024

First Submitted That Met QC Criteria

August 21, 2024

First Posted (Actual)

August 23, 2024

Study Record Updates

Last Update Posted (Actual)

August 23, 2024

Last Update Submitted That Met QC Criteria

August 21, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Stroke

Clinical Trials on Virtual Reality (VR) Therapy

Subscribe